![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Despite optimal treatment, myocardial infarction (MI) remains a major cause of death worldwide. Stem cell transplantation, as a promising therapy hoping to improve myocardial function and generate new myocardium, has been intensely studied for treating MI.
Objective: To summarize the recent advance of stem cell transplantation for treating MI in clinical trials and preclinical studies.
Results: Several types of adult stem cells have been applied to clinical trials and exerted beneficial effects against MI. The therapeutic effects of these stem cells are varied, modest and mostly depend on paracrine function. Embryonic stem cells and induced pluripotent stem cells, as well as their derivative cells, bring a new dawn for cardiac regeneration although they have not been applied in patients due to safety concerns. Feasible solutions are required to stress the safety issue, and to improve the survival, engraftment, migration, differentiation and synchronization with recipient myocardium of transplanted stem cells.
Conclusion: Stem cell transplantation for treating MI in clinical trials has achieved modest therapeutic effect. The hurdles limiting the stem cell function define the direction of further research.
Keywords: Stem cell, transplantation, myocardial infarction, regeneration, embryonic stem cell, induced pluripotent stem cell.
Current Stem Cell Research & Therapy
Title:Progress of Stem Cell Transplantation for Treating Myocardial Infarction
Volume: 12 Issue: 8
Author(s): Zhi Chen, Chunyu Zeng*Wei Eric Wang*
Affiliation:
- Department of Cardiology, Daping Hospital, Third Military Medical University, 10 Changjiang Branch Road, Chongqing 400042,China
- Department of Cardiology, Daping Hospital, Third Military Medical University, 10 Changjiang Branch Road, Chongqing 400042,China
Keywords: Stem cell, transplantation, myocardial infarction, regeneration, embryonic stem cell, induced pluripotent stem cell.
Abstract: Background: Despite optimal treatment, myocardial infarction (MI) remains a major cause of death worldwide. Stem cell transplantation, as a promising therapy hoping to improve myocardial function and generate new myocardium, has been intensely studied for treating MI.
Objective: To summarize the recent advance of stem cell transplantation for treating MI in clinical trials and preclinical studies.
Results: Several types of adult stem cells have been applied to clinical trials and exerted beneficial effects against MI. The therapeutic effects of these stem cells are varied, modest and mostly depend on paracrine function. Embryonic stem cells and induced pluripotent stem cells, as well as their derivative cells, bring a new dawn for cardiac regeneration although they have not been applied in patients due to safety concerns. Feasible solutions are required to stress the safety issue, and to improve the survival, engraftment, migration, differentiation and synchronization with recipient myocardium of transplanted stem cells.
Conclusion: Stem cell transplantation for treating MI in clinical trials has achieved modest therapeutic effect. The hurdles limiting the stem cell function define the direction of further research.
Export Options
About this article
Cite this article as:
Chen Zhi , Zeng Chunyu *, Wang Eric Wei *, Progress of Stem Cell Transplantation for Treating Myocardial Infarction, Current Stem Cell Research & Therapy 2017; 12 (8) . https://dx.doi.org/10.2174/1574888X12666170927114854
DOI https://dx.doi.org/10.2174/1574888X12666170927114854 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis
Current Pharmaceutical Design Editorial [Hot Topic: NMDA Receptors as Targets in Medicinal Chemistry (Guest Editor: Dr. William Metz)]
Current Topics in Medicinal Chemistry Reversal of Multidrug Resistance by Natural Substances from Plants
Current Topics in Medicinal Chemistry GPE and GPE Analogues as Promising Neuroprotective Agents
Mini-Reviews in Medicinal Chemistry Preface
Cardiovascular & Hematological Disorders-Drug Targets Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam
CNS & Neurological Disorders - Drug Targets Retrometabolic Syntheses of Astaxanthin (3,3-dihydroxy-β,β-carotene-4,4-dione) Conjugates: A Novel Approach to Oral and Parenteral Cardioprotection
Cardiovascular & Hematological Agents in Medicinal Chemistry Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential
Current Neuropharmacology Use of Angiotensin Receptor Blockers and Risk of Alzheimer’s Disease: A Class Effect?
Current Reviews in Clinical and Experimental Pharmacology Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
Current Pharmaceutical Biotechnology The Concept of Phenoptosis and its Usefulness for Controlling Aging
Current Aging Science Editorial [Hot Topic: Current Antithrombotic Management of ST Elevation Acute Coronary Syndromes in the Cath Lab – A Paradigm Shift (Guest Editor: Bernardo Cortese)]
Current Vascular Pharmacology Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Isomannide and Derivatives. Chemical and Pharmaceutical Applications
Mini-Reviews in Organic Chemistry Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis
Current Pharmaceutical Design Detection and Treatment of Alcohol-Induced Hypertension
Current Hypertension Reviews Clinical Profile of Mortality among Chronic Schizophrenic Patients: A Local Pilot Survey in Iran
Current Psychiatry Research and Reviews